A 38-gene model comprised of key TET2-associated genes shows additive utility to high-risk prostate cancer cases in the prognostication of biochemical recurrence

BACKGROUND: Early treatment of patients at risk for developing aggressive prostate cancer is able to delay metastasis and reduce mortality; as such, up-front identification of these patients is critical. Several risk classification systems, including CAPRA-S, are currently used for disease prognosti...

Descripción completa

Detalles Bibliográficos
Autores principales: Kamdar, Shivani, Fleshner, Neil E., Bapat, Bharati
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7530956/
https://www.ncbi.nlm.nih.gov/pubmed/33008340
http://dx.doi.org/10.1186/s12885-020-07438-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7530956/
https://www.ncbi.nlm.nih.gov/pubmed/33008340
http://dx.doi.org/10.1186/s12885-020-07438-4

Ejemplares similares